6 results
8-K
EX-10.2
CNSP
Cns Pharmaceuticals Inc
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders
8-K
EX-10.1
CNSP
Cns Pharmaceuticals Inc
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising
8-K
EX-10.1
CNSP
Cns Pharmaceuticals Inc
6 Jan 22
CNS Pharmaceuticals Announces $11.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
9:11am
Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising
S-1/A
EX-1.1
l5jn328t51vyrk x24l
16 Jul 19
IPO registration (amended)
1:23pm
- Prev
- 1
- Next